The LP.8.1-adapted BNT162b2 COVID-19 vaccine elicited a strong immune response and showed an acceptable safety profile in ...

Evidence of HIV-1 is uncommon among individuals receiving long-acting cabotegravir (LA CAB) for pre-exposure prophylaxis ...

Seasonal influenza vaccination reduces the risk for pediatric ED/UC visits, especially in children younger than 5 years.

Infants who received the MenACWY-TT vaccine demonstrated robust antibody responses against hypervirulent meningococcal ...

Measles infection in neonates ranges from asymptomatic to severe disease, requiring high clinician vigilance, prompt ...

An infectious disease expert discusses using motivational interviewing and empathetic communication to address vaccine ...

The recombinant zoster vaccine protects adults with HIV against cardiovascular complications such as incident heart failure ...

Treatment-experienced patients with HIV and viremia achieve high virologic suppression with long-acting CAB/RPV.

The Infectious Disease Advisor team will be covering emerging research and key takeaways from IDWeek 2026, as well as ...

META Older Latino adults show high motivation for RSV vaccination but face significant barriers to actual immunization.

Switching to a once-daily bictegravir/lenacapavir (BIC/LEN) single-tablet regimen is generally well tolerated through 48 ...

FDA approves Hibsago (bepirovirsen) with NrtI therapy for adult chronic hepatitis B without cirrhosis; phase 3 trials show up to 20% functional cure at 72 weeks.